Quantcast

Tulsa Clinic participating in a national study for Alzheimer's d - KOAM TV 7

Tulsa Clinic participating in a national study for Alzheimer's disease

Updated:
TULSA, OKLAHOMA -

Today in the U.S., more than five million people are living with mild-to-moderate Alzheimer's disease (AD). According to a recent study by the Alzheimer's Association, of those five million people living with mild-to-moderate AD, over 60,000 live in the state of Oklahoma. However, no new drug has been approved by the U.S. FDA for the treatment of AD since 2003.

To help address this gap, researchers at Tulsa Clinical Research are participating in a national study to evaluate the potential benefits of an investigational medication for patients with mild-to-moderate AD, which could help slow progression of the disease. Tulsa Clinical Research is currently enrolling patients in the study, called the NOBLE study.

People interested in participating can visit www.NOBLEStudy.org

To qualify for the NOBLE Study, the participant must meet the following criteria: 

  • Are aged 55-85 years old
  • Are receiving steady donepezil (Aricept®) or rivastigimine (Exelon® Patch) treatment
  • Are living in the community (not in a nursing home)
  • Have a study partner that has at least 10 hours of contact per week, who can attend study visits
  • Weigh no more than 220 pounds
# # #

Powered by Frankly

KOAM - Licensed to Pittsburg, Kansas
Send tips, ideas and press releases to: tips@koamtv.com
Send newsroom questions or comments to: comments@koamtv.com
Phone: (417) 624-0233 or (620) 231-0400
Web comments or questions: webmaster@koamtv.com
Newsroom Fax: (417) 624-3158

Powered by Frankly, Inc. All content © Copyright 2000 - 2018 KOAM. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.